BWG
CVS icon

Beta Wealth Group’s CVS Health CVS Stock Holding History

Beta Wealth Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
6,125
+297
+5% +$26.5K 0.24% 73
2026
Q1 		$419K Buy
5,828
+203
+4% +$15.6K 0.17% 91
2025
Q4 		$446K Sell
5,625
-1,498
-21% -$118K 0.18% 85
2025
Q3 		$537K Sell
7,123
-31,192
-81% -$2.14M 0.21% 80
2025
Q2 		$2.64M Buy
38,315
+487
+1% +$31.9K 0.97% 31
2025
Q1 		$2.56M Buy
37,828
+30,407
+410% +$1.82M 0.92% 31
2024
Q4 		$333K Sell
7,421
-39,542
-84% -$2.22M 0.15% 90
2024
Q3 		$2.95M Buy
46,963
+1,353
+3% +$78.9K 1.33% 25
2024
Q2 		$2.69M Buy
45,610
+39,187
+610% +$2.45M 1.28% 27
2024
Q1 		$512K Sell
6,423
-583
-8% -$44.5K 0.25% 64
2023
Q4 		$553K Buy
7,006
+4
+0.1% +$285 0.29% 54
2023
Q3 		$489K Buy
7,002
+202
+3% +$14.3K 0.29% 61
2023
Q2 		$470K Buy
6,800
+1,900
+39% +$135K 0.27% 64
2023
Q1 		$364K Buy
4,900
+400
+9% +$33.5K 0.21% 74
2022
Q4 		$419K Buy
4,500
+300
+7% +$28.9K 0.28% 61
2022
Q3 		$400K Buy
4,200
+200
+5% +$19.8K 0.29% 51
2022
Q2 		$371K Buy
4,000
+300
+8% +$29.3K 0.25% 55
2022
Q1 		$374K Buy
+3,700
New +$389K 0.25% 53

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Beta Wealth Group's CVS Position: Q2 2026 in Review

Beta Wealth Group increased its CVS Health (CVS) stake by 5.1% in Q2 2026, buying an estimated $26.5K and bringing the position to 6,125 shares worth $634K. The position accounts for 0.24% of the portfolio, ranked #73.

Beta Wealth Group first reported a position in CVS in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.95M in Q3 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Beta Wealth Group held 6,125 shares of CVS Health worth $634K as of Q2 2026.
  • Beta Wealth Group bought 297 CVS Health shares in Q2 2026, an estimated $26.5K.
  • CVS Health made up 0.24% of Beta Wealth Group's portfolio in Q2 2026, its #73 holding.
  • Beta Wealth Group first reported a position in CVS Health in Q1 2022 and has held it in 18 quarters since.
  • Beta Wealth Group's CVS Health position peaked at $2.95M in Q3 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Beta Wealth Group's 13F filing for Q2 2026, filed 24 Jul 2026.